Waters Corporation (WAT)
NYSE: WAT · Real-Time Price · USD
371.69
+0.53 (0.14%)
Nov 7, 2025, 4:00 PM EST - Market closed
Waters Revenue
Waters had revenue of $799.89M in the quarter ending September 27, 2025, with 8.05% growth. This brings the company's revenue in the last twelve months to $3.11B, up 6.90% year-over-year. In the year 2024, Waters had annual revenue of $2.96B with 0.07% growth.
Revenue (ttm)
$3.11B
Revenue Growth
+6.90%
P/S Ratio
7.12
Revenue / Employee
$408,637
Employees
7,600
Market Cap
22.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.96B | 1.97M | 0.07% |
| Dec 31, 2023 | 2.96B | -15.54M | -0.52% |
| Dec 31, 2022 | 2.97B | 186.08M | 6.68% |
| Dec 31, 2021 | 2.79B | 420.51M | 17.78% |
| Dec 31, 2020 | 2.37B | -41.23M | -1.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
WAT News
- 2 days ago - The London Company SMID Cap Vs. Russell 2500 Q3 2025 Top Contributors And Detractors - Seeking Alpha
- 3 days ago - Waters Corporation (WAT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Waters Corp raises annual profit forecast on stronger lab equipment demand - Reuters
- 3 days ago - Waters Corporation (NYSE: WAT) Reports Third Quarter 2025 Financial Results - PRNewsWire
- 25 days ago - Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics - PRNewsWire
- 5 weeks ago - Waters Corporation Schedules Third Quarter 2025 Earnings Conference Call - PRNewsWire
- 2 months ago - Waters Corporation (WAT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript) - Seeking Alpha
- 2 months ago - Waters Corporation to Present at the Wells Fargo Healthcare Conference - PRNewsWire